Financial Information-Sirio Pharma Co., Ltd.

R&D Capabilities

At SIRIO, innovation is at our core. In 2024, we invested over CNY 100 million in R&D. Backed by over 30 years of expertise, SIRIO has built a leading multidisciplinary R&D team, established five global R&D centers, obtained 107 invention patents, and developed a portfolio of more than 6000 mature formulations. We work alongside you to transform scientific leadership into product excellence and a lasting competitive edge.

Company Milestones

1993

SIRIO was founded

Began pharmaceutical manufacturing

2000

Started to provide contract manufacturing services for food and dietary supplements

2002

Launched the export business for food and dietary supplements

2003

Obtained pharmaceutical GMP certification and food GMP certicification

2007

Opened a second facility at the Shantou production site

Commenced operations at our gummy and solid dosage production facility, expanding to multi-formulation production capabilities

2010

Achieved U.S. NPA-cGMP certification and became the first formulation enterprise in China to achieve this certification^**According to CIC

Securing an internationally recognized validation of pharmaceutical‑grade quality standards

2012

Launched our first plant-based softgel production lineIntroduced liquid production lines

2013

Ranked first for six consecutive years in China's dietary supplements export market share^**According to CIC

Launched our first plant-based softgel production line

Achieved Australia's TGA GMP certification

2015

Brand-new testing center was put into use, laying the foundation for CNAS accreditation and strengthening quality control throughout the entire supply chain.

2016

Acquired Ayanda GmbH (Germany), now is Sirio Pharma Germany

Obtained UL certification (USA)

2018

Ma’anshan Health Industry Park started operation and we commenced scale production of our gummy

2019

Listed on the Shenzhen Stock Exchange (300791.SZ)

2021

Initiated the model program for the digital transformation of the nutrition product solution industry

2022

Established a R&D Center in Shanghai

Launched the Ma’anshan smart warehouse

2023

Acquired Best Formulations LLC (USA) Zhuhai Bonded Factory was put into operation

Shantou Industrial Park received the national "Green Factory" certification

2024

Launched a new automated packaging line in Sirio Pharma Germany

Our standard for Ubidecarenone Chewable Gels was included in the United States Pharmacopeia, making us the first Chinese company to participate in and contribute to United States Pharmacopeia

Established a pet nutrition manufacturing facility, marking our entry into the pet nutrition sector

2025

Established SIRIO Institute on Ageing

Our Thailand Industrial Park commenced construction